Phases out certain reimbursements for expenditures made by or on behalf of social services districts for medical assistance for needy persons, beginning with a 10% reduction for 2025, and ending with a 100% reduction for 2034, and remaining eliminated for each year thereafter.
Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.
Establishes through the department of health a drug checking services program to allow individuals to bring drugs or controlled substances and have them tested for contaminants, toxic substances, or hazardous compounds; requires the department to establish public health surveillance of the unregulated drug supply; provides exemptions for participants in the drug checking program from certain controlled substance offenses.
Codifies certain regulations of the workers' compensation board relating to access to prescription medication and coordination with workers' compensation board regulations governing network pharmacy use; requires the workers' compensation board to file a report on out-of-network pharmacy use within 3 years of the effective date.
Requires genetic testing results only be received by patients and health care providers providing direct care while health insurance companies only receive a record that the genetic testing was performed; provides insurers cannot require access to genetic testing results and cannot take adverse action against someone for not providing genetic testing results.
This bill creates the "Lab Services Accessibility Act," which modifies New York's public health law to expand exemptions for clinical laboratories providing specific public health services. It directly affects clinical laboratories and health service providers operating under public health programs, such as pregnancy testing, sexually transmitted infection screening, pandemic response, and care for underserved populations. Key provisions (Section 3) add new payment exemptions, allowing services for these programs to be covered without triggering certain regulatory requirements - specifically, by entities like hospitals, insurers, or public health initiatives. The law aims to streamline access to essential lab services by clarifying payment pathways for priority health needs.
Bill S 3689 amends the real property actions and proceedings law to protect tenants using medical marihuana. It prohibits landlords from evicting a tenant from a residential unit solely because of their certified medical use of medical marihuana. The bill establishes this as a defense for tenants in eviction proceedings. However, it also clarifies that landlords retain their legal rights to recover possession for any other lawful grounds not related to medical marihuana use.
Requires hospitals to have a registered professional nurse as a sitting and voting member of the governing entity responsible for developing a hospital's strategic plan, structure, systems, policies and programs.
Requires the administration of certain vaccines for children in accordance with regulations issued by the commissioner, utilizing generally accepted medical standards and based on recommendations of the American Academy of Pediatrics, the American Academy of Family Physicians, the American College of Obstetricians and Gynecologists, the American College of Physicians, the Advisory Committee on Immunization Practices, or other similar nationally or internationally recognized scientific organizations.
Relates to the establishment of regulations for administering immunizations taking into consideration the recommendations of the American Academy of Pediatrics, the American Academy of Family Physicians, the American College of Obstetricians and Gynecologists, the American College of Physicians, the advisory committee on immunization practices, any interstate body established for purposes of reviewing and making recommendations regarding immunization coverage and access, or other similar nationally or internationally recognized scientific organizations.
